CSNK1A1 gRNA (BRDN0001149315) Citations (1)
Originally described in: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE Nat Biotechnol. 2016 Jan 18. doi: 10.1038/nbt.3437. PubMed Journal
Articles Citing CSNK1A1 gRNA (BRDN0001149315)
| Articles |
|---|
| Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response. Park DE, Cheng J, Berrios C, Montero J, Cortes-Cros M, Ferretti S, Arora R, Tillgren ML, Gokhale PC, DeCaprio JA. Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):1027-1032. doi: 10.1073/pnas.1818798116. Epub 2018 Dec 31. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.